
According to a large new study published on Wednesday in the New England Journal of Medicine, males aged 16 to 29 have an increased risk of developing myocarditis after receiving a second dose of mRNA coronavirus vaccines manufactured by Pfizer-BioNtech or Moderna.
NYTimes Health | Disclosure
Comments
Post a Comment